Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Herscheid

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Nuclear Medicine|January 1, 1986
Evaluation of the renal scanning agent N-succinyldesferrioxamine B in dogsJ D Herscheid, H Isaacs, R B de Jong, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|December 1, 1992
Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89W E Meijs, J D Herscheid, H J Haisma, et al.
European Journal of Pharmacology|February 10, 1998
Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brainF G Custers, J E Leysen, J C Stoof, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and doseG W Visser, G C Gorree, G J Peters, et al.
European Journal of Nuclear Medicine|October 1, 1995
A simple and efficient method to remove free radioiodide from *I-radiopharmaceuticalsJ L Eersels, F G Custers, G J Ensing, et al.
Nuclear Medicine Communications|August 1, 1985
Synthesis and biodistribution of [18F]-5-fluorocytosineG W Visser, S Boele, G H Knops, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocolG W Visser, M Gerretsen, J D Herscheid, et al.
Journal of Medicinal Chemistry|August 1, 1978
Gliotoxin analogues as inhibitors of reverse transcriptase. 1. Effect of lipophilicityH C Ottenheijm, J D Herscheid, M W Tijhuis, et al.
European Journal of Nuclear Medicine|January 1, 1986
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidineG W Visser, O Zwaagstra, G C Gorree, et al.
Nuclear Medicine and Biology|April 1, 1996
18F-radiopharmacokinetics of [18F]-5-fluorouracil in a mouse bearing two colon tumors with a different 5-fluorouracil sensitivity: a study for a correlation with oncological resultsG W Visser, C L van der Wilt, R Wedzinga, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine|January 1, 1986
Evaluation of the renal scanning agent N-succinyldesferrioxamine B in dogsJ D Herscheid, H Isaacs, R B de Jong, et al.
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|December 1, 1992
Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89W E Meijs, J D Herscheid, H J Haisma, et al.
European Journal of Pharmacology|February 10, 1998
Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brainF G Custers, J E Leysen, J C Stoof, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and doseG W Visser, G C Gorree, G J Peters, et al.
European Journal of Nuclear Medicine|October 1, 1995
A simple and efficient method to remove free radioiodide from *I-radiopharmaceuticalsJ L Eersels, F G Custers, G J Ensing, et al.
Nuclear Medicine Communications|August 1, 1985
Synthesis and biodistribution of [18F]-5-fluorocytosineG W Visser, S Boele, G H Knops, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1993
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocolG W Visser, M Gerretsen, J D Herscheid, et al.
Journal of Medicinal Chemistry|August 1, 1978
Gliotoxin analogues as inhibitors of reverse transcriptase. 1. Effect of lipophilicityH C Ottenheijm, J D Herscheid, M W Tijhuis, et al.
European Journal of Nuclear Medicine|January 1, 1986
Synthesis and tumour-localizing properties of [18F]-5-fluorocytosine-arabinoside and [18F]-5-fluorocyclocytidineG W Visser, O Zwaagstra, G C Gorree, et al.
Nuclear Medicine and Biology|April 1, 1996
18F-radiopharmacokinetics of [18F]-5-fluorouracil in a mouse bearing two colon tumors with a different 5-fluorouracil sensitivity: a study for a correlation with oncological resultsG W Visser, C L van der Wilt, R Wedzinga, et al.
Pageof 3